AHK-Cu vs GHK-Cu: One Amino Acid Apart, Very Different Evidence

Our wider comparison of copper complexes, signal peptides and neuropeptide analogues explains why these two sit in a different class from Matrixyl or SNAP-8. This article goes one level deeper: what separates the two chemically, what each literature contains, and how much weight each can bear.

The short version is an asymmetry. GHK-Cu is among the most studied small peptides in wound and matrix biology. AHK-Cu is presented as its hair-focused relative, yet claims linking it to collagen or elastin have no AHK-Cu study behind them in PubMed.

The two compounds side by side

One amino acid, and why it was swapped

Glycine is the only amino acid without a side chain, just a hydrogen atom; alanine carries a methyl group. That is the whole structural difference. The peptide formulas differ by one CH₂ unit (14.03 g/mol), so AHK-Cu reads slightly heavier than GHK-Cu whichever charge or salt form a datasheet quotes.

GHK entered the literature in 1973 as a human serum tripeptide that prolonged the survival of normal liver cells in culture (Pickart and Thaler, 1973). By 1980 Pickart's group had shown that it complexes copper(II) and increases copper uptake into cultured hepatoma cells, and that several tripeptides sharing the histidyl-lysyl linkage were nearly as active (Pickart et al., 1980). The first position looked open to substitution.

ProCyte's patent filings followed that logic. US patent 5,550,183 (granted 1996, from a family dating to 1985) lists alanine, serine and valine as possible replacements for glycine and claims AHK-Cu as a compound, although its worked examples concern GHK derivatives rather than AHK-Cu (Pickart, 1996).

Copper binding: a shared motif, unequally measured

Coordination chemists group copper-binding peptides by where histidine sits. Peptides with histidine second, the NH₂-Xxx-His family, hold Cu(II) through three of their own nitrogens (amine, amide and imidazole) plus one external ligand, and GHK is the canonical example (Gonzalez et al., 2017). Its complex is a dimer in the crystal but a monomer in solution, with a labile fourth ligand and fast copper exchange (Hureau et al., 2011). Isothermal titration calorimetry gives a conditional dissociation constant of about 7 × 10^-14 M at pH 7.4, binding mainly 1:1 (Trapaidze et al., 2012).

AHK also has histidine second, so it should bind copper the same way. One wrinkle: Ala-His-Lys is also residues two to four of the N-terminus of human serum albumin, Asp-Ala-His-Lys, where histidine sits third and forms a different, four-nitrogen site (Hureau et al., 2011). Without the aspartate, histidine moves to second place, so free AHK should behave like GHK, not albumin.

That is inference from the motif, not measurement. We found no published structure, binding constant or exchange study for AHK-Cu, so claims that it binds copper more tightly or is more stable than GHK-Cu lack any published support we could find.

What the GHK-Cu evidence contains

The GHK-Cu literature is broad, and reads best sorted by model.

• Cell culture: GHK-Cu stimulated collagen synthesis in fibroblast cultures independently of cell number (Maquart et al., 1988). The same paper noted a GHK triplet within type I collagen, suggesting the peptide could be released at wound sites.
• Rodent: in a rat wound chamber model, GHK-Cu increased collagen, glycosaminoglycan and total protein content in a concentration-dependent way; a control tripeptide had no significant effect (Maquart et al., 1993).
• Human: a multicentre, randomised, evaluator-blinded, placebo-controlled trial in diabetic neuropathic foot ulcers reported greater median closure with a GHK-Cu gel than with vehicle (Mulder et al., 1994). A small randomised study after CO₂ laser resurfacing (13 patients completed) found no objective difference in redness or wrinkles, only higher patient-rated satisfaction (Miller et al., 2006).
• Gene expression: an independent team led from Boston University used the Broad Institute's Connectivity Map to identify GHK as reversing an emphysema gene signature; GHK also restored collagen remodelling by fibroblasts from lungs with chronic obstructive pulmonary disease (Campbell et al., 2012). The often quoted figure that GHK shifts about 31% of human genes by 50% or more comes from Pickart's group, using the same database of cultured cancer cell lines (Pickart and Margolina, 2018).

Read candidly, this literature is long, coherent and partly independent, but mostly preclinical. Its human trials are few, small or dated, with mixed outcomes, and much of the broad summarising was written by the compound's discoverer.

What the AHK-Cu evidence contains

A PubMed title and abstract search for AHK-Cu returns one study. Pyo and colleagues at Seoul National University tested it on isolated human hair follicles in organ culture and on cultured dermal papilla cells, specialised fibroblasts important for follicle growth (Pyo et al., 2007). AHK-Cu stimulated follicle elongation and cell proliferation, raised the Bcl-2/Bax ratio and lowered the apoptosis markers cleaved caspase-3 and PARP, though the fall in apoptotic cell numbers was not statistically significant.

That is the dedicated evidence base: one group, one paper, tissue in culture, no animal model, no human trial. The paper's opening summary of fibroblast effects is background on "the tripeptide-copper complex", wording long used for GHK-Cu, not new AHK-Cu data. The only other AHK paper we found concerns a vitamin C-linked AHK without copper in a mouse muscle cell line (Jung et al., 2018).

What transfers between them, and what does not

• Chemistry transfers in outline, numbers do not. The shared motif makes similar copper coordination likely, but the measured affinity and structures of GHK-Cu are not AHK-Cu data.
• Biology does not transfer by default. The 1980 result shows His-Lys tripeptides behaving alike in one cell assay, not that AHK-Cu reproduces the collagen, wound or gene-expression findings for GHK-Cu. No PubMed record we found tests the two side by side.
• "Hair peptide" and "skin peptide" are labels, not selectivity. They describe where each literature sits. The patent claiming AHK-Cu is mostly about GHK-Cu and its derivatives, and no study we found compares the two in a follicle model.

The bottom line

GHK-Cu and AHK-Cu are chemically close and evidentially far apart: five decades of work, thin in humans but substantial, against a patent claim and one culture study. For research planning, GHK-Cu is the reference compound and AHK-Cu a lightly characterised analogue whose basic properties, from copper affinity to stability, remain largely unmeasured. UK supply details for GHK-Cu are on the GHK-Cu UK page, and Peptx supplies both strictly for laboratory research use.

References

1. Campbell JD, et al. (2012). A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Medicine. PubMed 22937864
2. Gonzalez P, et al. (2017). Cu(II) Binding to the Peptide Ala-His-His, a Chimera of the Canonical Cu(II)-Binding Motifs Xxx-His and Xxx-Zzz-His. Inorganic Chemistry. PubMed 29190078
3. Hureau C, et al. (2011). X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties. Chemistry: A European Journal. PubMed 21780203
4. Jung JI, et al. (2018). Vitamin C-linker-conjugated tripeptide AHK stimulates BMP-2-induced osteogenic differentiation of mouse myoblast C2C12 cells. Differentiation. PubMed 29567599
5. Maquart FX, et al. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. PubMed 3169264
6. Maquart FX, et al. (1993). In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. Journal of Clinical Investigation. PubMed 8227353
7. Miller TR, et al. (2006). Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Archives of Facial Plastic Surgery. PubMed 16847171
8. Mulder GD, et al. (1994). Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair and Regeneration. PubMed 17147644
9. Pickart L, Thaler MM. (1973). Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature New Biology. PubMed 4349963
10. Pickart L, et al. (1980). Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature. PubMed 7453802
11. Pickart L, Margolina A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. PubMed 29986520
12. Pickart LR. (1996). Metal-peptide compositions and methods for stimulating hair growth. US Patent 5,550,183, assigned to ProCyte Corporation. Google Patents US5550183A
13. Pyo HK, et al. (2007). The effect of tripeptide-copper complex on human hair growth in vitro. Archives of Pharmacal Research. PubMed 17703734
14. Trapaidze A, et al. (2012). Thermodynamic study of Cu2+ binding to the DAHK and GHK peptides by isothermal titration calorimetry (ITC) with the weaker competitor glycine. Journal of Biological Inorganic Chemistry. PubMed 21898044